Regeneron Pharmaceuticals (REGN) on on Thursday reported adjusted earnings of $9.89 per share on $2.53 billion in sales for its first quarter. In response, Regeneron stock edged higher.
On average, analysts polled by FactSet expected Regeneron to earn $8.74 per share on $2.53 billion in sales.
In the year-earlier period, Regeneron earnings were $6.60 per share and the company reported $1.83 billion in sales.
The biotech company did not provide full-year EPS or sales guidance. Analysts called for adjusted income of $46.62 per share and $12 billion in sales.
In premarket trading on the stock market today, Regeneron stock rose 0.7%.
More to follow.
Follow Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE: